Sinergium Biotech S.A.
Sinergium Biotech is an Argentine biopharmaceutical company specializing in the research, development, production, and commercialization of vaccines and high-complexity biopharmaceutical products. It aims to improve health and preserve life through innovative strategies, strategic alliances, and local production of vaccines, including mRNA technology, to reduce dependency on imports and foster regional self-sufficiency. The company is committed to quality, responsibility, efficiency, and innovation, with a vision to be a leader in the supply of high-quality vaccines both locally and internationally.
Industries
Nr. of Employees
large (251-1000)
Sinergium Biotech S.A.
Garin, Buenos Aires, Argentina, South America
Products
Inactivated hepatitis A vaccine (national supply)
Inactivated hepatitis A vaccine supplied for national immunization programmes.
Intravesical immunotherapy for non‑muscle invasive bladder cancer
Intravesical immunotherapy formulation used as adjuvant treatment to reduce recurrence of superficial urothelial carcinoma after resection.
20‑valent pneumococcal conjugate vaccine (planned local production)
Planned local production of a 20‑valent pneumococcal conjugate vaccine to expand serotype coverage and supply doses for national immunization and regional distribution.
Inactivated hepatitis A vaccine (national supply)
Inactivated hepatitis A vaccine supplied for national immunization programmes.
Intravesical immunotherapy for non‑muscle invasive bladder cancer
Intravesical immunotherapy formulation used as adjuvant treatment to reduce recurrence of superficial urothelial carcinoma after resection.
20‑valent pneumococcal conjugate vaccine (planned local production)
Planned local production of a 20‑valent pneumococcal conjugate vaccine to expand serotype coverage and supply doses for national immunization and regional distribution.
Services
Contract manufacturing (aseptic fill‑and‑finish)
On‑site aseptic fill‑and‑finish services for vaccines and biologics, including prefilled syringe and vial formats and integration with technology transfer projects.
Technology transfer and consortium implementation
Management and operational delivery of technology transfer projects for vaccine platforms, including partner coordination, training and process replication.
Vaccine R&D and preclinical development
Research, formulation and preclinical testing services for vaccine candidates, including immunogenicity studies and preparation for early clinical development.
Public‑private manufacturing partnership design and regional supply planning
Design and implementation of collaborative agreements to enable local production of vaccines and coordinated regional distribution through pooled procurement.
Contract manufacturing (aseptic fill‑and‑finish)
On‑site aseptic fill‑and‑finish services for vaccines and biologics, including prefilled syringe and vial formats and integration with technology transfer projects.
Technology transfer and consortium implementation
Management and operational delivery of technology transfer projects for vaccine platforms, including partner coordination, training and process replication.
Vaccine R&D and preclinical development
Research, formulation and preclinical testing services for vaccine candidates, including immunogenicity studies and preparation for early clinical development.
Public‑private manufacturing partnership design and regional supply planning
Design and implementation of collaborative agreements to enable local production of vaccines and coordinated regional distribution through pooled procurement.
Expertise Areas
- Vaccine development and manufacturing
- mRNA platform development and technology transfer
- Conjugate vaccine process development and scale-up
- Aseptic fill‑and‑finish for syringes and vials
Key Technologies
- mRNA vaccine platforms
- Lipid nanoparticle (LNP) formulation
- Conjugate vaccine manufacturing processes
- Aseptic high-throughput filling